Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, Habener JF
Caution notes Magnesium can cause loose stools in some people, especially citrate
Efficacy and safety of the once-daily GLP-1 receptor agonist lixisenatide in monotherapy: A randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono)
There is no fixed end point, as the treatment plan is entirely personalised to your goals and health profile.
As of early 2026, no peer-reviewed human clinical trials for TB-500 specifically have been published
In experimental wound healing models, TB-500 treatment increases capillary density by 40-50% while improving functional blood flow restoration, demonstrating translation of cellular angiogenic activity into meaningful tissue-level perfusion benefits